{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:43:32Z","timestamp":1788871412440,"version":"build-2803163510"},"reference-count":164,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["1-08-CR-48"],"award-info":[{"award-number":["1-08-CR-48"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"crossref","award":["1-2008-1025"],"award-info":[{"award-number":["1-2008-1025"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"crossref","award":["4-200-421"],"award-info":[{"award-number":["4-200-421"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Michigan Diabetes Research and Training Center","award":["5P60-DK020572"],"award-info":[{"award-number":["5P60-DK020572"]}]},{"name":"Michigan Diabetes Research and Training Center","award":["5P60-DK020572"],"award-info":[{"award-number":["5P60-DK020572"]}]},{"name":"Animal Models of Diabetic Complications Consortium","award":["U01-DK076160"],"award-info":[{"award-number":["U01-DK076160"]}]},{"DOI":"10.13039\/100008456","name":"Taubman Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008456","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Neurology Research and Discovery"},{"name":"Doris Duke Foundation","award":["HL092237"],"award-info":[{"award-number":["HL092237"]}]},{"name":"NIH","award":["HL092237-02S109"],"award-info":[{"award-number":["HL092237-02S109"]}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1053\/j.ajkd.2009.10.050","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T04:07:58Z","timestamp":1262232478000},"page":"365-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Management of Diabetic Neuropathy in CKD"],"prefix":"10.1053","volume":"55","author":[{"given":"Rodica","family":"Pop-Busui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Kretzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib1","first-page":"83A","article-title":"Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease [abstract]","volume":"3","author":"Kamal-Bahl","year":"2006","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1464-5491.1991.tb01576.x","article-title":"Risk factors for non-ischaemic foot ulceration in diabetic nephropathy","volume":"8","author":"Fernando","year":"1991","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2009.10.050_bib3","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1007\/BF00587633","article-title":"Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation","volume":"34","author":"Navarro","year":"1991","journal-title":"Diabetologia"},{"issue":"9","key":"10.1053\/j.ajkd.2009.10.050_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1464-5491.1993.tb00173.x","article-title":"Mortality in diabetic patients with cardiovascular autonomic neuropathy","volume":"10","author":"Rathmann","year":"1993","journal-title":"Diabet Med"},{"issue":"278","key":"10.1053\/j.ajkd.2009.10.050_bib5","first-page":"635","article-title":"Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics","volume":"75","author":"Sampson","year":"1990","journal-title":"Q J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1525-139x.2002.0006a.x","article-title":"How can the cardiac death rate be reduced in dialysis patients?","volume":"15","author":"Manjunath","year":"2002","journal-title":"Semin Dial"},{"issue":"9","key":"10.1053\/j.ajkd.2009.10.050_bib7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/ndt\/12.9.1816","article-title":"Dialysis patient outcomes in Europe vs the USA","volume":"12","author":"Locatelli","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2009.10.050_bib8","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1681\/ASN.V12112411","article-title":"Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease","volume":"12","author":"Locatelli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2009.10.050_bib9","series-title":"USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2006"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ndt\/gfm634","article-title":"Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV","volume":"23","author":"Ranpuria","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.1998.v32.pm9708605","article-title":"Autonomic dysregulation in patients awaiting kidney transplantation","volume":"32","author":"Hathaway","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2337\/diacare.12.4.259","article-title":"Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy","volume":"12","author":"Zander","year":"1989","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000046274","article-title":"The role of autonomic neuropathy in the genesis of intradialytic hypotension","volume":"21","author":"Chang","year":"2001","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2796.2000.00690.x","article-title":"Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia?","volume":"248","author":"Laaksonen","year":"2000","journal-title":"J Intern Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2009.10.050_bib15","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1093\/ndt\/5.suppl_1.128","article-title":"Autonomic neuropathy and secondary hyperparathyroidism in uraemia","volume":"5","author":"Spallone","year":"1990","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.amjhyper.2005.02.002","article-title":"Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure","volume":"18","author":"Johansson","year":"2005","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2004.07.012","article-title":"Neurological complications in renal failure: a review","volume":"107","author":"Brouns","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib18","first-page":"12","article-title":"Pain assessment and management for a dialysis patient with diabetic peripheral neuropathy","volume":"16","author":"Innis","year":"2006","journal-title":"CANNT J"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1056-8727(00)00054-4","article-title":"Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes","volume":"14","author":"Stella","year":"2000","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00125-004-1617-y","article-title":"Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus","volume":"48","author":"Witte","year":"2005","journal-title":"Diabetologia"},{"issue":"pt 5","key":"10.1053\/j.ajkd.2009.10.050_bib21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/brain\/awn052","article-title":"Activity-dependent excitability changes suggest Na+\/K+ pump dysfunction in diabetic neuropathy","volume":"131","author":"Krishnan","year":"2008","journal-title":"Brain"},{"key":"10.1053\/j.ajkd.2009.10.050_bib22","first-page":"E311","article-title":"Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve","volume":"246","author":"Greene","year":"1984","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","article-title":"Diabetic neuropathy: mechanisms to management","volume":"120","author":"Edwards","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/dmrr.625","article-title":"Diabetic neuropathy and oxidative stress","volume":"22","author":"Pop-Busui","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"issue":"6865","key":"10.1053\/j.ajkd.2009.10.050_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib26","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1053\/j.ajkd.2009.10.050_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4684-5445-1_1","article-title":"Parathyroid hormone: a uremic toxin","volume":"223","author":"Massry","year":"1987","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib28","first-page":"F1","article-title":"Parathyroid hormone metabolism and its potential as a uremic toxin","volume":"239","author":"Slatopolsky","year":"1980","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib29","first-page":"205","article-title":"Uremic toxicity: the middle molecule hypothesis revisited","volume":"14","author":"Vanholder","year":"1994","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/WNL.39.10.1364","article-title":"Ouabain reverses conduction disturbances in single demyelinated nerve fibers","volume":"39","author":"Kaji","year":"1989","journal-title":"Neurology"},{"issue":"pt 9","key":"10.1053\/j.ajkd.2009.10.050_bib31","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/brain\/awh558","article-title":"Altered motor nerve excitability in end-stage kidney disease","volume":"128","author":"Krishnan","year":"2005","journal-title":"Brain"},{"issue":"pt 6","key":"10.1053\/j.ajkd.2009.10.050_bib32","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/brain\/awl099","article-title":"Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease","volume":"129","author":"Krishnan","year":"2006","journal-title":"Brain"},{"issue":"pt 7","key":"10.1053\/j.ajkd.2009.10.050_bib33","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awg153","article-title":"Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination","volume":"126","author":"Craner","year":"2003","journal-title":"Brain"},{"issue":"pt 6","key":"10.1053\/j.ajkd.2009.10.050_bib34","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/brain\/awf123","article-title":"Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia","volume":"125","author":"Kiernan","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.20713","article-title":"Uremic neuropathy: clinical features and new pathophysiological insights","volume":"35","author":"Krishnan","year":"2007","journal-title":"Muscle Nerve"},{"issue":"27","key":"10.1053\/j.ajkd.2009.10.050_bib36","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib37","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/HJH.0b013e32832b521b","article-title":"Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?","volume":"27","author":"Siddiqi","year":"2009","journal-title":"J Hypertens"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000184117","article-title":"Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure","volume":"45","author":"Axelrod","year":"1987","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ki.1981.127","article-title":"Mechanisms of autonomic nervous system dysfunction in uremia","volume":"20","author":"Campese","year":"1981","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib40","first-page":"559","article-title":"Elevation of serum and ventricular norepinephrine content in the diabetic rat","volume":"33","author":"Paulson","year":"1981","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.CIR.103.6.782","article-title":"Antioxidants and myocardial contractility: illuminating the \u201cdark side\u201d of beta-adrenergic receptor activation?","volume":"103","author":"Givertz","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0361-9230(82)90086-7","article-title":"Effects of streptozotocin diabetes on the noradrenergic innervation of the rat heart: a longitudinal histofluorescence and neurochemical study","volume":"8","author":"Felten","year":"1982","journal-title":"Brain Res Bull"},{"issue":"23","key":"10.1053\/j.ajkd.2009.10.050_bib43","doi-asserted-by":"crossref","first-page":"17578","DOI":"10.1074\/jbc.M001174200","article-title":"cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures","volume":"275","author":"Scacco","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.CIR.100.3.305","article-title":"Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes","volume":"100","author":"Iwai-Kanai","year":"1999","journal-title":"Circulation"},{"issue":"13","key":"10.1053\/j.ajkd.2009.10.050_bib45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/01.CIR.98.13.1329","article-title":"Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway","volume":"98","author":"Communal","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2337\/diacare.26.4.986","article-title":"Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy","volume":"26","author":"Colberg","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ndt\/16.3.566","article-title":"Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients","volume":"16","author":"Giordano","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"193","key":"10.1053\/j.ajkd.2009.10.050_bib48","first-page":"95","article-title":"The natural history of diabetic autonomic neuropathy","volume":"49","author":"Ewing","year":"1980","journal-title":"Q J Med"},{"issue":"6346","key":"10.1053\/j.ajkd.2009.10.050_bib49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br Med J"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib50","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/diacare.9.6.648","article-title":"Diabetic autonomic neuropathy: present insights and future prospects","volume":"9","author":"Ewing","year":"1986","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib52","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/WNL.46.5.1470","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy","volume":"46","year":"1996","journal-title":"Neurology"},{"issue":"12","key":"10.1053\/j.ajkd.2009.10.050_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM197403212901203","article-title":"Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension","volume":"290","author":"Kersh","year":"1974","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib54","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/ndt\/16.8.1657","article-title":"Autonomic insufficiency as a factor contributing to dialysis-induced hypotension","volume":"16","author":"Sato","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.ndt.a027354","article-title":"No change in automatic function tests during uncomplicated haemodialysis","volume":"11","author":"Ligtenberg","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib56","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.CIR.100.8.813","article-title":"Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus","volume":"100","author":"Di Carli","year":"1999","journal-title":"Circulation"},{"issue":"17","key":"10.1053\/j.ajkd.2009.10.050_bib57","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJM199704243361703","article-title":"Effects of cardiac sympathetic innervation on coronary blood flow","volume":"336","author":"Di Carli","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib58","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0735-1097(98)00128-4","article-title":"Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy","volume":"31","author":"Stevens","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/diab.42.7.1017","article-title":"Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function","volume":"42","author":"Nitenberg","year":"1993","journal-title":"Diabetes"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib60","first-page":"1133","article-title":"[Coronary vasoconstriction induced by acetylcholine in young smokers with normal angiographic coronary vessels]","volume":"86","author":"Nitenberg","year":"1993","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0735-1097(94)00459-4","article-title":"Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia","volume":"25","author":"Langer","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"1 pt 2","key":"10.1053\/j.ajkd.2009.10.050_bib62","first-page":"I215","article-title":"Sudden cardiac death","volume":"76","author":"Schwartz","year":"1987","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib63","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.CIR.87.5.1442","article-title":"Sudden cardiac death","volume":"87","author":"Willich","year":"1993","journal-title":"Circulation"},{"issue":"21","key":"10.1053\/j.ajkd.2009.10.050_bib64","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM197605202942107","article-title":"Neural activity and ventricular fibrillation","volume":"294","author":"Lown","year":"1976","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib65","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","article-title":"The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis","volume":"26","author":"Maser","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib66","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1067\/mhj.2000.111112","article-title":"Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension","volume":"140","author":"Brown","year":"2000","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib67","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9149(87)90305-5","article-title":"Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study","volume":"60","author":"Levy","year":"1987","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib68","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/ndt\/gfh361","article-title":"Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients","volume":"19","author":"Nishimura","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2009.10.050_bib69","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3","article-title":"Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects","volume":"20","author":"Low","year":"1997","journal-title":"Muscle Nerve"},{"issue":"1-2","key":"10.1053\/j.ajkd.2009.10.050_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-1838(96)00107-5","article-title":"Cardiovascular autonomic nervous system tests: determination of normative values and effect of confounding variables","volume":"62","author":"Gelber","year":"1997","journal-title":"J Auton Nerv Syst"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib71","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use","volume":"93","year":"1996","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib72","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib73","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0735-1097(93)90039-4","article-title":"Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans","volume":"22","author":"Allman","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib74","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.98.10.961","article-title":"Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk","volume":"98","author":"Stevens","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0026-0495(99)90016-1","article-title":"Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography","volume":"48","author":"Stevens","year":"1999","journal-title":"Metabolism"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib76","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/diab.44.5.543","article-title":"Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM","volume":"44","author":"Kreiner","year":"1995","journal-title":"Diabetes"},{"issue":"11","key":"10.1053\/j.ajkd.2009.10.050_bib77","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/BF00401768","article-title":"Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy","volume":"38","author":"Schnell","year":"1995","journal-title":"Diabetologia"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib78","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diab.45.6.801","article-title":"Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients","volume":"45","author":"Schnell","year":"1996","journal-title":"Diabetes"},{"issue":"9","key":"10.1053\/j.ajkd.2009.10.050_bib79","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9149(96)00538-3","article-title":"Increased QT dispersion and cardiac adrenergic dysinnervation in diabetic patients with autonomic neuropathy","volume":"78","author":"Shimabukuro","year":"1996","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib80","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.19.10.1083","article-title":"Demonstration of regional sympathetic denervation of the heart in diabetes","volume":"19","author":"Turpeinen","year":"1996","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1053\/j.ajkd.2009.10.050_bib81","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.jacc.2004.09.033","article-title":"Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction","volume":"44","author":"Pop-Busui","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib82","first-page":"1287","article-title":"Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine","volume":"34","author":"DeGrado","year":"1993","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib83","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115185","article-title":"Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography","volume":"87","author":"Schwaiger","year":"1991","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.97.2.174","article-title":"Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart","volume":"97","author":"Ungerer","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib85","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1152\/jappl.2001.91.3.1199","article-title":"Automated quantification of sympathetic beat-by-beat activity, independent of signal quality","volume":"91","author":"Hamner","year":"2001","journal-title":"J Appl Physiol"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib86","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1464-5491.1995.tb00555.x","article-title":"Reduction of gangrene and amputations in diabetic renal transplant patients: the role of a special foot clinic","volume":"12","author":"Foster","year":"1995","journal-title":"Diabet Med"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib87","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.1999.00668.x","article-title":"Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population","volume":"56","author":"Eggers","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib88","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.ajkd.2009.04.035","article-title":"The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"54","author":"Combe","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib89","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/mus.880110702","article-title":"Report and recommendations of the San Antonio Conference on Diabetic Neuropathy","volume":"11","year":"1988","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib90","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":"Diabetic somatic neuropathies","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib91","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/dmrr.552","article-title":"Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies","volume":"21","author":"Adriaensen","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1053\/j.ajkd.2009.10.050_bib92","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib93","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ana.410380607","article-title":"Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial","volume":"38","year":"1995","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib94","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001250050924","article-title":"The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)","volume":"41","year":"1998","journal-title":"Diabetologia"},{"issue":"11","key":"10.1053\/j.ajkd.2009.10.050_bib95","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s001250050586","article-title":"Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study","volume":"39","author":"Tesfaye","year":"1996","journal-title":"Diabetologia"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib96","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1053\/j.ajkd.2009.10.050_bib97","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"16","key":"10.1053\/j.ajkd.2009.10.050_bib98","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","article-title":"Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"290","year":"2003","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2009.10.050_bib99","first-page":"58:A63","article-title":"Cardiac autonomic dysfunction predicts cardiovascular mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial","author":"Pop-Busui","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"issue":"9131","key":"10.1053\/j.ajkd.2009.10.050_bib101","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"9131","key":"10.1053\/j.ajkd.2009.10.050_bib102","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib104","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1440-1797.2006.00680.x","article-title":"Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis","volume":"11","author":"Ondocin","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5507\/bp.2004.012","article-title":"Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency","volume":"148","author":"Weinbergova","year":"2004","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib107","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/ajkd.1998.v31.pm9531175","article-title":"Determinants of heart rate variability in chronic hemodialysis patients","volume":"31","author":"Tamura","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"17","key":"10.1053\/j.ajkd.2009.10.050_bib108","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure","volume":"340","author":"Ligtenberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib109","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.HYP.0000256530.39695.a3","article-title":"Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment","volume":"49","author":"Neumann","year":"2007","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2215\/CJN.02360706","article-title":"Predictors of survival after cardiac arrest in outpatient hemodialysis clinics","volume":"2","author":"Pun","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2009.10.050_bib111","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib112","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000232593","article-title":"Beta-blocker prescription and outcomes in hemodialysis patients from the Japan Dialysis Outcomes and Practice Patterns Study","volume":"113","author":"Nakao","year":"2009","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib113","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","article-title":"Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study","volume":"62","author":"Foley","year":"2002","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib114","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/039139889601901003","article-title":"Autonomic neuropathy in hemodialysis patients treated with recombinant human erythropoietin","volume":"19","author":"Stojcheva-Taneva","year":"1996","journal-title":"Int J Artif Organs"},{"issue":"11","key":"10.1053\/j.ajkd.2009.10.050_bib115","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","article-title":"Beta blockers in the management of chronic kidney disease","volume":"70","author":"Bakris","year":"2006","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib116","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-002-0869-7","article-title":"Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in type I diabetic patients with abnormal albuminuria","volume":"45","author":"Ebbehoj","year":"2002","journal-title":"Diabetologia"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib117","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejheart.2005.10.005","article-title":"Decreased survival in diabetic patients with heart failure due to systolic dysfunction","volume":"8","author":"Kamalesh","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib118","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5414\/CNP61316","article-title":"Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial","volume":"61","author":"Tory","year":"2004","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib119","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.102.5.484","article-title":"What type of beta-blocker should be used to treat chronic heart failure?","volume":"102","author":"Bristow","year":"2000","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2009.10.050_bib120","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/ndt\/16.suppl_1.67","article-title":"Sympathetic overactivity and arterial hypertension in renal failure","volume":"16","author":"Orth","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2009.10.050_bib121","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/ndt\/gfh288","article-title":"The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey","volume":"19","author":"Paoletti","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib122","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/diacare.24.3.495","article-title":"Anemia with erythropoietin deficiency occurs early in diabetic nephropathy","volume":"24","author":"Bosman","year":"2001","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1053\/j.ajkd.2009.10.050_bib123","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM199308263290904","article-title":"Treatment of orthostatic hypotension with erythropoietin","volume":"329","author":"Hoeldtke","year":"1993","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib124","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1464-5491.1999.00172.x","article-title":"Erythropoietin depletion and anaemia in diabetes mellitus","volume":"16","author":"Winkler","year":"1999","journal-title":"Diabet Med"},{"issue":"10","key":"10.1053\/j.ajkd.2009.10.050_bib125","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/ndt\/gfh420","article-title":"Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review","volume":"19","author":"Prakash","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib126","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/08860220802249025","article-title":"Midodrine-induced vascular ischemia in a hemodialysis patient: a case report and literature review","volume":"30","author":"Rubinstein","year":"2008","journal-title":"Ren Fail"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib127","doi-asserted-by":"crossref","first-page":"P21","DOI":"10.1159\/000066655","article-title":"Effect of sertraline hydrochloride on cardiac autonomic dysfunction in patients with hemodialysis-induced hypotension","volume":"93","author":"Yalcin","year":"2003","journal-title":"Nephron Physiol"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ki.1991.236","article-title":"Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure","volume":"40","author":"Agarwal","year":"1991","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.1990.2","article-title":"Insulin in the acute renal adaptation to dietary phosphate restriction in the rat","volume":"37","author":"Allon","year":"1990","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib130","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/ndt\/gfh306","article-title":"Predictors of haemodynamic instability and heart rate variability during haemodialysis","volume":"19","author":"Rubinger","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib131","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000099013","article-title":"Alteration of heart rate variability parameters in nondiabetic hemodialysis patients","volume":"27","author":"Tong","year":"2007","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib132","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/JDI-120028541","article-title":"Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study","volume":"26","author":"Dursun","year":"2004","journal-title":"Ren Fail"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib133","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/08860220701857308","article-title":"Blood pressure and heart rate variability in patients on conventional or sodium-profiling hemodialysis","volume":"30","author":"Rubinger","year":"2008","journal-title":"Ren Fail"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib134","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.37.4.589","article-title":"Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood","volume":"37","author":"Max","year":"1987","journal-title":"Neurology"},{"issue":"19","key":"10.1053\/j.ajkd.2009.10.050_bib135","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy","volume":"326","author":"Max","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib136","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","article-title":"The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms","volume":"42","author":"Sindrup","year":"1990","journal-title":"Pain"},{"issue":"1-2","key":"10.1053\/j.ajkd.2009.10.050_bib137","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib138","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1526-4637.2006.00207.x","article-title":"Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study","volume":"7","author":"Raskin","year":"2006","journal-title":"Pain Med"},{"issue":"8","key":"10.1053\/j.ajkd.2009.10.050_bib139","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"},{"issue":"21","key":"10.1053\/j.ajkd.2009.10.050_bib140","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib141","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib142","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"issue":"4","key":"10.1053\/j.ajkd.2009.10.050_bib143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib144","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"issue":"5","key":"10.1053\/j.ajkd.2009.10.050_bib146","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0b013e3283311e13","article-title":"Pharmacology and treatment of neuropathic pains","volume":"22","author":"Jensen","year":"2009","journal-title":"Curr Opin Neurol"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2009.10.050_bib147","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1111\/j.1526-4637.2006.00179.x","article-title":"Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review","volume":"8","author":"Barrett","year":"2007","journal-title":"Pain Med"},{"key":"10.1053\/j.ajkd.2009.10.050_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007938","article-title":"Pregabalin for acute and chronic pain in adults","volume":"3","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib149","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib151","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/j.1552-4604.1995.tb05020.x","article-title":"Disposition of gabapentin in anuric subjects on hemodialysis","volume":"35","author":"Wong","year":"1995","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib152","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0013-9580.2005.20804.x","article-title":"Gabapentin-induced myoclonus in end-stage renal disease","volume":"46","author":"Zhang","year":"2005","journal-title":"Epilepsia"},{"issue":"3","key":"10.1053\/j.ajkd.2009.10.050_bib153","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/emj.2007.053470","article-title":"Gabapentin toxicity: an important cause of altered consciousness in patients with uraemia","volume":"25","author":"Hung","year":"2008","journal-title":"Emerg Med J"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib154","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/0003-4819-137-1-200207020-00029","article-title":"Gabapentin toxicity requiring intubation in a patient receiving long-term hemodialysis [letter]","volume":"137","author":"Jones","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2009.10.050_bib155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0885-3924(00)00218-9","article-title":"Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review","volume":"20","author":"Collins","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"10.1053\/j.ajkd.2009.10.050_bib156","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1592\/phco.27.11.1571","article-title":"Antidepressant agents for the treatment of chronic pain and depression","volume":"27","author":"Jann","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ajkd.2009.10.050_bib157","article-title":"Anticonvulsant drugs for acute and chronic pain","volume":"3","author":"Wiffen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib158","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"1-2","key":"10.1053\/j.ajkd.2009.10.050_bib159","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"issue":"13","key":"10.1053\/j.ajkd.2009.10.050_bib160","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"issue":"9697","key":"10.1053\/j.ajkd.2009.10.050_bib161","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2009.10.050_bib162","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/diacare.15.2.159","article-title":"Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy","volume":"15","year":"1992","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1053\/j.ajkd.2009.10.050_bib163","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1053\/j.ajkd.2009.10.050_bib164","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.jrn.2007.10.010","article-title":"High-tone external muscle stimulation in end-stage renal disease: effects on symptomatic diabetic and uremic peripheral neuropathy","volume":"18","author":"Klassen","year":"2008","journal-title":"J Ren Nutr"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638609014486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638609014486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:53:19Z","timestamp":1759456399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638609014486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":164,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0272638609014486"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2009.10.050","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Management of Diabetic Neuropathy in CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2009.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}